Chicago Partners Investment Group LLC Gilead Sciences, Inc. Transaction History

Chicago Partners Investment Group LLC

$2.33 Billion
Q1 2024

A detailed history of Chicago Partners Investment Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 6,349 shares of GILD stock, worth $423,414. This represents 0.02% of its overall portfolio holdings.

Number of Shares

6,349

Previous 6,446 1.5%

Holding current value

$423,414

Previous $522,000 10.92%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$71.58 - $87.29 $6,943 - $8,467	-97 Reduced 1.5%	6,349 $465,000
Q4 2023 Feb 23, 2024	BUY	$73.27 - $83.09 $33,118 - $37,556	452 Added 7.54%	6,446 $522,000
Q3 2023 Oct 26, 2023	BUY	$73.94 - $80.67 $27,801 - $30,331	376 Added 6.69%	5,994 $449,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $17,634 - $20,114	232 Added 4.31%	5,618 $432,000
Q1 2023 Apr 26, 2023	BUY	$77.31 - $88.08 $463 - $528	6 Added 0.11%	5,386 $446,000

Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $11,030 - $15,836	177 Added 3.4%	5,380 $461,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $101,337 - $115,753	1,702 Added 48.61%	5,203 $424,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $12,582 - $14,172	218 Added 6.64%	3,501 $209,000
Q1 2022 May 20, 2022	SELL	$57.92 - $72.58 $28,264 - $35,419	-488 Reduced 12.94%	3,283 $208,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $27,249 - $30,928	-420 Reduced 10.02%	3,771 $230,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $15,433 - $16,650	228 Added 5.75%	4,191 $292,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $20,056 - $21,914	316 Added 8.66%	3,963 $272,000
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $12,000 - $13,691	200 Added 5.8%	3,647 $240,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $29,344 - $33,436	-518 Reduced 13.06%	3,447 $231,000
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $1,987 - $2,498	-32 Reduced 0.8%	3,965 $233,000
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $73,786 - $85,680	1,020 Added 34.26%	3,997 $298,000
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $186,449 - $238,814	2,977 New	2,977 $250,000
Q1 2019 Apr 22, 2019	SELL	$62.53 - $70.05 $282,823 - $316,836	-4,523 Closed	0 $0
Q4 2018 Jan 11, 2019	BUY	$60.54 - $79.0 $1,210 - $1,580	20 Added 0.44%	4,523 $308,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $7,128 - $7,892	-100 Reduced 2.17%	4,503 $319,000
Q2 2018 Aug 31, 2018	BUY	$64.88 - $75.68 $106,857 - $124,644	1,647 Added 55.72%	4,603 $326,000
Q1 2018 Apr 27, 2018	BUY	$72.84 - $88.8 $142,038 - $173,160	1,950 Added 193.84%	2,956 $0
Q4 2017 Mar 28, 2018	SELL	$71.15 - $83.52 $78,265 - $91,872	-1,100 Reduced 52.23%	1,006 $0
Q3 2017 Nov 22, 2017	BUY	$72.11 - $85.47 $151,863 - $179,999	2,106	2,106 $0

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.

Account

Chicago Partners Investment Group LLC Gilead Sciences, Inc. Transaction History